{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:34:22Z","timestamp":1786984462570,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"MEYS \u2013 NPS I","award":["LO1413"],"award-info":[{"award-number":["LO1413"]}]},{"name":"MH CZ - DRO","award":["00209805"],"award-info":[{"award-number":["00209805"]}]},{"name":"MH CZ - DRO","award":["65269705"],"award-info":[{"award-number":["65269705"]}]},{"DOI":"10.13039\/501100001824","name":"GACR","doi-asserted-by":"publisher","award":["P206\/12\/G151"],"award-info":[{"award-number":["P206\/12\/G151"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.antiviral.2019.01.019","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T19:53:55Z","timestamp":1548964435000},"page":"185-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The role of miR-409-3p in regulation of HPV16\/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions"],"prefix":"10.1016","volume":"163","author":[{"given":"Lucia","family":"Sommerova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Bouchalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvika","family":"Jasickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0071-6506","authenticated-orcid":false,"given":"Vladimir","family":"Rak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Jandakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iveta","family":"Selingerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bartosik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borivoj","family":"Vojtesek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6139-2664","authenticated-orcid":false,"given":"Roman","family":"Hrstka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.01.019_bib1","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1349-7006.2002.tb02478.x","article-title":"Differential suppression of human cervical cancer cell growth by adenovirus delivery of p53 in vitro: arrest phase of cell cycle is dependent on cell line","volume":"93","author":"Ahn","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.antiviral.2019.01.019_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137397","article-title":"CDKN3 mRNA as a biomarker for survival and therapeutic target in cervical cancer","volume":"10","author":"Barron","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.01.019_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.01.019_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bios.2016.04.035","article-title":"Electrochemical chip-based genomagnetic assay for detection of high-risk human papillomavirus DNA","volume":"83","author":"Bartosik","year":"2016","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.antiviral.2019.01.019_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc."},{"key":"10.1016\/j.antiviral.2019.01.019_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: human papillomavirus and cervical cancer--burden and assessment of causality","author":"Bosch","year":"2003","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.antiviral.2019.01.019_bib7","series-title":"ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Czech Republic","author":"Bruni","year":"2017"},{"key":"10.1016\/j.antiviral.2019.01.019_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12896-016-0292-7","article-title":"A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer","volume":"16","author":"Campomenosi","year":"2016","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.01.019_bib10","first-page":"3825","article-title":"Low expression of miR-409-3p is a prognostic marker for breast cancer","volume":"20","author":"Cao","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.antiviral.2019.01.019_bib11","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1128\/JVI.00103-08","article-title":"How does tobacco smoke contribute to cervical carcinogenesis?","volume":"82","author":"Castle","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165395","article-title":"TCGA expedition: a data acquisition and management system for TCGA data","volume":"11","author":"Chandran","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.01.019_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","article-title":"Widespread microRNA repression by Myc contributes to tumorigenesis","volume":"40","author":"Chang","year":"2008","journal-title":"Nat. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.01.019_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/rmv.1823","article-title":"Signaling pathways in HPV-associated cancers and therapeutic implications","volume":"25","author":"Chen","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib15","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","article-title":"The role of microRNAs in the pathogenesis of autoimmune diseases","volume":"15","author":"Chen","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.antiviral.2019.01.019_bib16","doi-asserted-by":"crossref","DOI":"10.3727\/096504017X15138991620238","article-title":"MiRNA-409-3p enhances cisplatin-sensitivity of ovarian cancer cells by blocking the autophagy mediated by Fip200","author":"Cheng","year":"2018","journal-title":"Oncol. Res."},{"key":"10.1016\/j.antiviral.2019.01.019_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2144\/000113083","article-title":"TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays","volume":"46","author":"Geback","year":"2009","journal-title":"Biotechniques"},{"key":"10.1016\/j.antiviral.2019.01.019_bib19","first-page":"2561","article-title":"Unique microRNA expression profiles in cervical cancer","volume":"33","author":"Gocze","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.antiviral.2019.01.019_bib20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bjc.2012.294","article-title":"Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation","volume":"107","author":"Hall","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.antiviral.2019.01.019_bib21","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/ijc.29618","article-title":"A systematic study on dysregulated microRNAs in cervical cancer development","volume":"138","author":"He","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2019.01.019_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1155\/2013\/761537","article-title":"AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients","volume":"35","author":"Hrstka","year":"2013","journal-title":"Dis. Markers"},{"key":"10.1016\/j.antiviral.2019.01.019_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/07357907.2017.1309546","article-title":"Tamoxifen-dependent induction of AGR2 is associated with increased aggressiveness of endometrial cancer cells","volume":"35","author":"Hrstka","year":"2017","journal-title":"Cancer Investig."},{"key":"10.1016\/j.antiviral.2019.01.019_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/IGC.0b013e31819d8a5c","article-title":"Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status","volume":"19","author":"Hublarova","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.antiviral.2019.01.019_bib25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/carcin\/bgs140","article-title":"microRNA involvement in human cancer","volume":"33","author":"Iorio","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.antiviral.2019.01.019_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5317\/wjog.v2.i1.1","article-title":"Burden of gynaecological cancers in developing countries","volume":"2","author":"Iyoke","year":"2013","journal-title":"World J. Obstet. Gynecol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib27","first-page":"286","article-title":"Cell intrinsic & extrinsic factors in cervical carcinogenesis","volume":"130","author":"Jayshree","year":"2009","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.antiviral.2019.01.019_bib28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4161\/cam.36224","article-title":"An introduction to the wound healing assay using live-cell microscopy","volume":"8","author":"Jonkman","year":"2014","journal-title":"Cell Adhes. Migrat."},{"key":"10.1016\/j.antiviral.2019.01.019_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1476-4598-13-80","article-title":"miR-375 activates p21 and suppresses telomerase activity by coordinately regulating HPV E6\/E7, E6AP, CIP2A, and 14-3-3zeta","volume":"13","author":"Jung","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.antiviral.2019.01.019_bib30","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3390\/jcm4051126","article-title":"Human papillomavirus: current and future RNAi therapeutic strategies for cervical cancer","volume":"4","author":"Jung","year":"2015","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.antiviral.2019.01.019_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-6433-8_6","article-title":"STarMir tools for prediction of microRNA binding sites","volume":"1490","author":"Kanoria","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-1-4939-3127-9_30","article-title":"Expression profiles of estrogen-regulated MicroRNAs in breast cancer cells","volume":"1366","author":"Katchy","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019679","article-title":"TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT","volume":"6","author":"Lalaoui","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.01.019_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molcel.2010.09.027","article-title":"MicroRNA functions in stress responses","volume":"40","author":"Leung","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2019.01.019_bib35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12032-015-0510-5","article-title":"Meta-analysis of microRNA expression profiling studies in human cervical cancer","volume":"32","author":"Li","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib36","first-page":"936","article-title":"MicroRNA-409 inhibits the proliferative ability of cervical carcinoma cells by regulating AKT","volume":"22","author":"Li","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.antiviral.2019.01.019_bib37","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1038\/s41598-017-06032-2","article-title":"A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis","volume":"7","author":"Liang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.01.019_bib38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s13238-015-0142-8","article-title":"Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes","volume":"6","author":"Lin","year":"2015","journal-title":"Prot. Cell"},{"key":"10.1016\/j.antiviral.2019.01.019_bib39","doi-asserted-by":"crossref","first-page":"62914","DOI":"10.18632\/oncotarget.17516","article-title":"MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.antiviral.2019.01.019_bib40","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1093\/nar\/gkt435","article-title":"CLIP-based prediction of mammalian microRNA binding sites","volume":"41","author":"Liu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2019.01.019_bib41","doi-asserted-by":"crossref","first-page":"15681","DOI":"10.3390\/ijms140815681","article-title":"Impaired pre-mRNA processing and altered architecture of 3' untranslated regions contribute to the development of human disorders","volume":"14","author":"Michalova","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.antiviral.2019.01.019_bib42","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/jid.2013.222","article-title":"Indoleamine 2,3-dioxygenase activity contributes to local immune suppression in the skin expressing human papillomavirus oncoprotein e7","volume":"133","author":"Mittal","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib43","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1007\/s13277-015-3976-z","article-title":"Telomerase and the process of cervical carcinogenesis","volume":"36","author":"Nachajova","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib44","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2019.01.019_bib45","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.3390\/molecules19056263","article-title":"MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance","volume":"19","author":"Pedroza-Torres","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2019.01.019_bib46","doi-asserted-by":"crossref","first-page":"14301","DOI":"10.1074\/jbc.M111.337642","article-title":"MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7","volume":"287","author":"Peng","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.01.019_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011780","article-title":"MicroRNA expression variability in human cervical tissues","volume":"5","author":"Pereira","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.01.019_bib48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/bs.ircmb.2017.04.002","article-title":"MicroRNAs in neurodegenerative diseases","volume":"334","author":"Quinlan","year":"2017","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib49","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1261\/rna.5248604","article-title":"Fast and effective prediction of microRNA\/target duplexes","volume":"10","author":"Rehmsmeier","year":"2004","journal-title":"RNA"},{"key":"10.1016\/j.antiviral.2019.01.019_bib50","doi-asserted-by":"crossref","first-page":"W114","DOI":"10.1093\/nar\/gku376","article-title":"STarMir: a web server for prediction of microRNA binding sites","volume":"42","author":"Rennie","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2019.01.019_bib51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2199-8-118","article-title":"RNA extraction from ten year old formalin-fixed paraffin-embedded breast cancer samples: a comparison of column purification and magnetic bead-based technologies","volume":"8","author":"Ribeiro-Silva","year":"2007","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","article-title":"Worldwide burden of gynaecological cancer: the size of the problem","volume":"20","author":"Sankaranarayanan","year":"2006","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4149\/neo_2010_03_264","article-title":"MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients","volume":"57","author":"Slaby","year":"2010","journal-title":"Neoplasma"},{"key":"10.1016\/j.antiviral.2019.01.019_bib54","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2019.01.019_bib55","series-title":"Cancer Facts & Figures 2018","author":"Society","year":"2018"},{"key":"10.1016\/j.antiviral.2019.01.019_bib56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.antiviral.2019.01.019_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040745","article-title":"The role of MicroRNAs in myocardial infarction: from molecular mechanism to clinical application","volume":"18","author":"Sun","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.antiviral.2019.01.019_bib58","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08199","article-title":"Modulation of microRNA processing by p53","volume":"460","author":"Suzuki","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.01.019_bib59","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3892\/ijmm.2016.2492","article-title":"miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy","volume":"37","author":"Tan","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.antiviral.2019.01.019_bib60","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1038\/s41598-017-02217-x","article-title":"Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data","volume":"7","author":"Taylor","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.01.019_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172661","article-title":"Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali","volume":"12","author":"Teguete","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.01.019_bib62","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.27713","article-title":"Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe","volume":"132","author":"Tjalma","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2019.01.019_bib63","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1373\/clinchem.2013.212985","article-title":"Genomics of cervical cancer and the role of human papillomavirus pathobiology","volume":"60","author":"Uyar","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.antiviral.2019.01.019_bib64","series-title":"Comparison of the miRNA Profiles in HPV-Positive and HPV-Negative Tonsillar Tumors and a Model System of Human Keratinocyte Clones","author":"Vojtechova","year":"2016"},{"key":"10.1016\/j.antiviral.2019.01.019_bib65","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1159\/000366337","article-title":"MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met","volume":"34","author":"Wan","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.antiviral.2019.01.019_bib66","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.ajpath.2011.07.037","article-title":"miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1","volume":"179","author":"Wang","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib67","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.1401430111","article-title":"microRNAs are biomarkers of oncogenic human papillomavirus infections","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.01.019_bib68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.gene.2016.03.021","article-title":"MicroRNA-409-3p inhibits osteosarcoma cell migration and invasion by targeting catenin-delta1","volume":"584","author":"Wu","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.antiviral.2019.01.019_bib69","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/bioinformatics\/btt014","article-title":"miRCancer: a microRNA-cancer association database constructed by text mining on literature","volume":"29","author":"Xie","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2019.01.019_bib70","article-title":"Regulation of viral oncogenesis by microRNAs","volume":"1","author":"Xu","year":"2014","journal-title":"Mol. Cell Oncol."},{"key":"10.1016\/j.antiviral.2019.01.019_bib71","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbrc.2016.06.006","article-title":"miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2","volume":"476","author":"Zhang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2019.01.019_bib72","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.5301\/ijbm.5000261","article-title":"MiR-411 functions as a tumor suppressor in renal cell cancer","volume":"32","author":"Zhang","year":"2017","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.antiviral.2019.01.019_bib73","first-page":"633","article-title":"MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3","volume":"39","author":"Zhao","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.antiviral.2019.01.019_bib74","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbagrm.2011.05.005","article-title":"Regulation of cellular miRNA expression by human papillomaviruses","volume":"1809","author":"Zheng","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2019.01.019_bib75","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1038\/onc.2011.581","article-title":"MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers","volume":"31","author":"Zheng","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2019.01.019_bib76","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3727\/096504016X14611963142173","article-title":"The downregulation of MicroRNA-10b and its role in cervical cancer","volume":"24","author":"Zou","year":"2016","journal-title":"Oncol. Res."},{"key":"10.1016\/j.antiviral.2019.01.019_bib77","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jnci\/92.9.690","article-title":"Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis","volume":"92","author":"zur Hausen","year":"2000","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421830370X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421830370X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:09Z","timestamp":1759062669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421830370X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":77,"alternative-id":["S016635421830370X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.01.019","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of miR-409-3p in regulation of HPV16\/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}